Buscar
Mostrando ítems 1-10 de 14
Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D). Clinical and diagnostic aspects, and a new treatment. An update
(Sociedad Argentina de Pediatría, 2017-06)
Lysosomal acid lipase deficiency (LAL-D) is stilla little recognized genetic disease with significantmorbidity and mortality in children and adults.This document provides guidance on whento suspect LAL-D and how to diagnose ...
Detection of the E8SJM mutation in the LIPA gene, by real-time PCR, for the investigation of cholesteryl ester storage diseaseDetección de la mutación E8SJM en el gen LIPA, por PCR en tiempo real, para la investigación de la enfermedad por almacenamiento de ésteres de colesterol
(Universidad Nacional Mayor de San Marcos, Facultad de Medicina Humana, 2018)
Padronização da análise molecular do gene LIPA e investigação de variantes em família brasileira com suspeita diagnóstica de deficiência de lipase ácida lisossomal
(Universidade Federal de São Paulo (UNIFESP), 2019-10-30)
Wolman's disease and cholesterol and triglyceride ester storage (CESD) are caused by deficiency or lack of lipase enzyme activity lysosomal acid (LAL); these diseases have as common characteristic the accumulation of ...
Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants
(Elsevier, 2013-02-15)
Bovine viral diarrhea virus (BVDV) is considered an important cause of economic loss within bovine herds worldwide. In Argentina, only the use of inactivated vaccines is allowed, however, the efficacy of inactivated BVDV ...
Deficiência da Lipase Ácida Lisossômica (LAL-D): uma causa subdiagnosticada de dislipidemia e alterações da função hepática
(Universidade Federal de São Paulo (UNIFESP), 2020-06-25)
Lysosomal acid lipase (LAL) is the enzyme encoded by the LIPA gene; deficiency of this enzyme leads to a congenital lysosomal disorder called Lysosomal Acid Lipase Deficiency (LAL-D). LAL is essential for lipid metabolism ...
Caracterización histopatológica de lesiones benignas de la mama en mujeres del departamento de Sucre, Colombia. Periodo 2012-2013
(Universidad de Sucre, 2015-07-02)
¿Cuál el grado de cumplimiento de las metas perfil metabólicas de acuerdo a la guía de NCEP - ATP III en pacientes con enfermedad coronaria en una institución hospitalaria?
(Universidad Autónoma de Bucaramanga UNABFacultad Ciencias de la SaludEspecialización en Epidemiología, 2015)
Las dislipidemia son trastornos caracterizados por un aumento de los niveles de colesterol y/o triglicérido con una prevalencia en nuestra población entre un 40-50% en la población > 50 años, lo cual aumenta el riesgo de ...